Tarsus Pharmaceuticals (TARS) Cash & Equivalents (2019 - 2026)
Tarsus Pharmaceuticals (TARS) reported Cash & Equivalents of $224.95 million for Q4 2023, up 213.9% from $71.66 million a year earlier.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Cash & Equivalents (2019 - 2026) Analysis & Trends
Dating back to Q3 2019, Tarsus Pharmaceuticals' Cash & Equivalents record includes 14 quarters.
- Cash & Equivalents has a four-year compound annual growth rate of 40.3% (FY2019 to FY2023).
- By year, Cash & Equivalents came in at $71.66 million in FY2022 (-58.2%), $171.33 million in FY2021 (+1.9%), $168.13 million in FY2020 (+189.9%) and $58 million in FY2019.
- The Q4 2023 figure ranks as the highest quarterly Cash & Equivalents since Q2 2022.
- Year over year, Cash & Equivalents gained in three of the last four quarters, with growth averaging 51.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2021 (growth of 232.6%); the low point was Q4 2022 (a decline of 58.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Tarsus Pharmaceuticals | 3.64 Bn | 2.07 Bn | 180.68 Mn | 136.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 136.53 Mn |
| Jun 30, 2026 | 204.60 Mn |
| Mar 31, 2026 | 102.19 Mn |
| Dec 31, 2025 | 183.64 Mn |
| Sep 30, 2025 | 112.72 Mn |
| Jun 30, 2025 | 96.65 Mn |
| Mar 31, 2025 | 175.79 Mn |
| Dec 31, 2024 | 94.82 Mn |
| Sep 30, 2024 | 176.21 Mn |
| Jun 30, 2024 | 181.10 Mn |
| Mar 31, 2024 | 193.71 Mn |
| Dec 31, 2023 | 224.95 Mn |
| Sep 30, 2023 | 226.67 Mn |
| Jun 30, 2023 | 106.77 Mn |
| Mar 31, 2023 | 66.00 Mn |
| Dec 31, 2022 | 71.66 Mn |
| Sep 30, 2022 | 169.49 Mn |
| Jun 30, 2022 | 245.40 Mn |
| Mar 31, 2022 | 175.01 Mn |
| Dec 31, 2021 | 171.33 Mn |
API Access
Tarsus Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();